Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
PLoS Genet ; 9(9): e1003817, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24068975

RESUMEN

Loss of heterozygosity (LOH) at tumor suppressor loci is a major contributor to cancer initiation and progression. Both deletions and mitotic recombination can lead to LOH. Certain chromosomal loci known as common fragile sites are susceptible to DNA lesions under replication stress, and replication stress is prevalent in early stage tumor cells. There is extensive evidence for deletions stimulated by common fragile sites in tumors, but the role of fragile sites in stimulating mitotic recombination that causes LOH is unknown. Here, we have used the yeast model system to study the relationship between fragile site instability and mitotic recombination that results in LOH. A naturally occurring fragile site, FS2, exists on the right arm of yeast chromosome III, and we have analyzed LOH on this chromosome. We report that the frequency of spontaneous mitotic BIR events resulting in LOH on the right arm of yeast chromosome III is higher than expected, and that replication stress by low levels of polymerase alpha increases mitotic recombination 12-fold. Using single-nucleotide polymorphisms between the two chromosome III homologs, we mapped the locations of recombination events and determined that FS2 is a strong hotspot for both mitotic reciprocal crossovers and break-induced replication events under conditions of replication stress.


Asunto(s)
Sitios Frágiles del Cromosoma/genética , Replicación del ADN/genética , Pérdida de Heterocigocidad , Mitosis/genética , Cromosomas Fúngicos/genética , Intercambio Genético , Roturas del ADN de Doble Cadena , Reparación del ADN/genética , Inestabilidad Genómica , Recombinación Genética , Saccharomyces cerevisiae/genética
2.
G3 (Bethesda) ; 11(10)2021 09 27.
Artículo en Inglés | MEDLINE | ID: mdl-34568913

RESUMEN

Long-tract gene conversions (LTGC) can result from the repair of collapsed replication forks, and several mechanisms have been proposed to explain how the repair process produces this outcome. We studied LTGC events produced from repair collapsed forks at yeast fragile site FS2. Our analysis included chromosome sizing by contour-clamped homogeneous electric field electrophoresis, next-generation whole-genome sequencing, and Sanger sequencing across repair event junctions. We compared the sequence and structure of LTGC events in our cells to the expected qualities of LTGC events generated by proposed mechanisms. Our evidence indicates that some LTGC events arise from half-crossover during BIR, some LTGC events arise from gap repair, and some LTGC events can be explained by either gap repair or "late" template switch during BIR. Also based on our data, we propose that models of collapsed replication forks be revised to show not a one-end double-strand break (DSB), but rather a two-end DSB in which the ends are separated in time and subject to gap repair.


Asunto(s)
Replicación del ADN , Saccharomyces cerevisiae , Reparación del ADN/genética , Conversión Génica , Recombinación Genética , Saccharomyces cerevisiae/genética
3.
Genetics ; 204(1): 115-28, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27343237

RESUMEN

Replication stress causes breaks at chromosomal locations called common fragile sites. Deletions causing loss of heterozygosity (LOH) in human tumors are strongly correlated with common fragile sites, but the role of gene conversion in LOH at fragile sites in tumors is less well studied. Here, we investigated gene conversion stimulated by instability at fragile site FS2 in the yeast Saccharomyces cerevisiae In our screening system, mitotic LOH events near FS2 are identified by production of red/white sectored colonies. We analyzed single nucleotide polymorphisms between homologs to determine the cause and extent of LOH. Instability at FS2 increases gene conversion 48- to 62-fold, and conversions unassociated with crossover represent 6-7% of LOH events. Gene conversion can result from repair of mismatches in heteroduplex DNA during synthesis-dependent strand annealing (SDSA), double-strand break repair (DSBR), and from break-induced replication (BIR) that switches templates [double BIR (dBIR)]. It has been proposed that SDSA and DSBR typically result in shorter gene-conversion tracts than dBIR. In cells under replication stress, we found that bidirectional tracts at FS2 have a median length of 40.8 kb and a wide distribution of lengths; most of these tracts are not crossover-associated. Tracts that begin at the fragile site FS2 and extend only distally are significantly shorter. The high abundance and long length of noncrossover, bidirectional gene-conversion tracts suggests that dBIR is a prominent mechanism for repair of lesions at FS2, thus this mechanism is likely to be a driver of common fragile site-stimulated LOH in human tumors.


Asunto(s)
Sitios Frágiles del Cromosoma , Saccharomyces cerevisiae/genética , Rotura Cromosómica , Cromosomas Fúngicos , Intercambio Genético , Roturas del ADN de Doble Cadena , Reparación del ADN , Replicación del ADN , ADN de Hongos/genética , Conversión Génica/genética , Pérdida de Heterocigocidad , Recombinación Genética , Proteínas de Saccharomyces cerevisiae/genética
4.
FASEB J ; 17(13): 1889-91, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12897064

RESUMEN

Complement fragment 5a (C5a)-C5a receptor (C5aR) signaling plays an essential role in neutrophil innate immunity. Blockade of either the ligand or the receptor improves survival rates in experimental sepsis. In the current study, sepsis was induced in rats by cecal ligation/puncture. Early in sepsis C5aR content on neutrophils significantly dropped, reached the nadir at 24 h after onset of sepsis, and progressively elevated thereafter. Western-blot, RT-PCR, and confocal microscopy analyses revealed that the loss and re-expression of C5aR during sepsis might be due, at least in part, to the receptor internalization and reconstitution. The reduction and reconstitution of C5aR correlate with the loss and restoration of innate immune functions of blood neutrophils (chemotaxis and reactive oxygen species production), respectively. Quantitative measurements of C5aR on blood neutrophils are highly predictive of survival or death during sepsis. These data suggest that neutrophil C5aR content represents an essential component of an efficient defense system in sepsis and may serve as a prognostic marker for the outcome.


Asunto(s)
Antígenos CD/metabolismo , Neutrófilos/inmunología , Receptores de Complemento/metabolismo , Sepsis/inmunología , Animales , Complemento C5a/biosíntesis , Modelos Inmunológicos , Pronóstico , Transporte de Proteínas , Ratas , Receptor de Anafilatoxina C5a , Sepsis/diagnóstico , Análisis de Supervivencia
5.
FASEB J ; 16(12): 1567-74, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12374779

RESUMEN

Innate immune functions are known to be compromised during sepsis, often with lethal consequences. There is also evidence in rats that sepsis is associated with excessive complement activation and generation of the potent anaphylatoxin C5a. In the presence of a cyclic peptide antagonist (C5aRa) to the C5a receptor (C5aR), the binding of murine 125I-C5a to murine neutrophils was reduced, the in vitro chemotactic responses of mouse neutrophils to mouse C5a were markedly diminished, the acquired defect in hydrogen peroxide (H2O2) production of C5a-exposed neutrophils was reversed, and the lung permeability index (extravascular leakage of albumin) in mice after intrapulmonary deposition of IgG immune complexes was markedly diminished. Mice that developed sepsis after cecal ligation/puncture (CLP) and were treated with C5aRa had greatly improved survival rates. These data suggest that C5aRa interferes with neutrophil responses to C5a, preventing C5a-induced compromise of innate immunity during sepsis, with greatly improved survival rates after CLP.


Asunto(s)
Inmunidad Innata/efectos de los fármacos , Oligopéptidos/farmacología , Receptores de Complemento/antagonistas & inhibidores , Sepsis/prevención & control , Animales , Antígenos CD , Quimiotaxis de Leucocito/efectos de los fármacos , Complemento C5a/metabolismo , Complemento C5a/farmacología , Relación Dosis-Respuesta a Droga , Inflamación/inmunología , Inflamación/prevención & control , Enfermedades Pulmonares/inmunología , Enfermedades Pulmonares/prevención & control , Masculino , Ratones , Neutrófilos/citología , Neutrófilos/metabolismo , Oligopéptidos/sangre , Oligopéptidos/síntesis química , Consumo de Oxígeno/efectos de los fármacos , Cavidad Peritoneal/citología , Unión Proteica/efectos de los fármacos , Receptor de Anafilatoxina C5a , Sepsis/inmunología , Sepsis/mortalidad , Tasa de Supervivencia
6.
J Immunol ; 170(12): 6115-24, 2003 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-12794141

RESUMEN

Using peptides that represent linear regions of the powerful complement activation product, C5a, or loops that connect the four alpha helices of C5a, we have defined the ability of these peptides to reduce binding of (125)I-C5a to human neutrophils, inhibit chemotactic responses of neutrophils to C5a, and reduce H(2)O(2) production in neutrophils stimulated with PMA. The data have defined likely sites of interaction of C5a with C5aR. The peptides had no functional activity per se on neutrophils and did not interfere with neutrophil responses to the unrelated chemotactic peptide, N-formyl-Met-Leu-Phe. Although previous data have suggested that there are two separate sites on C5a reactive with C5aR, the current data suggest that C5a interacts with C5aR in a manner that engages three discontinuous regions of C5a.


Asunto(s)
Antígenos CD/química , Antígenos CD/fisiología , Complemento C5a/química , Complemento C5a/fisiología , Receptores de Complemento/química , Receptores de Complemento/fisiología , Secuencia de Aminoácidos , Antígenos CD/metabolismo , Unión Competitiva/inmunología , Inhibición de Migración Celular , Quimiotaxis de Leucocito , Complemento C5a/antagonistas & inhibidores , Complemento C5a/metabolismo , Relación Dosis-Respuesta Inmunológica , Humanos , Peróxido de Hidrógeno/antagonistas & inhibidores , Peróxido de Hidrógeno/metabolismo , Radioisótopos de Yodo/metabolismo , Datos de Secuencia Molecular , N-Formilmetionina Leucil-Fenilalanina/farmacología , Neutrófilos/efectos de los fármacos , Neutrófilos/inmunología , Neutrófilos/metabolismo , Fragmentos de Péptidos/antagonistas & inhibidores , Fragmentos de Péptidos/síntesis química , Fragmentos de Péptidos/metabolismo , Fragmentos de Péptidos/fisiología , Receptor de Anafilatoxina C5a , Receptores de Complemento/metabolismo , Relación Estructura-Actividad , Acetato de Tetradecanoilforbol/antagonistas & inhibidores , Acetato de Tetradecanoilforbol/farmacología
7.
Am J Respir Cell Mol Biol ; 29(4): 432-8, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-14500254

RESUMEN

Complement is necessary for defense against lung infection with Pseudomonas aeruginosa in mice. We studied in vitro interactions between complement and P. aeruginosa and in vivo effects of complement depletion to better understand this relationship. In vitro, P. aeruginosa strain UI-18 was resistant to killing by mouse serum. However, C3 opsonized the organism (via the alternative and mannose binding lectin [MBL] pathways), and C5 convertase activity on the bacterial surface was demonstrated. In vivo, compared with normal mice, complement-deficient mice experienced higher mortality and failed to sterilize their bronchoalveolar space within 24 h of inoculation. These changes did not seem to be a result of decreased inflammation because complement-deficient mice had normal neutrophil recruitment, greater lung myeloperoxidase content, and, by 24 h, a 35-fold higher level of the CXC chemokine KC. Lung static pressure-volume curves were abnormal in infected animals but were significantly more so in complement deficient mice. These data indicate that although P. aeruginosa is resistant to serum killing, C3 opsonization and C5 convertase assembly occur on its surface. This interaction in vivo plays a central role in host survival beyond just recruitment and activation of phagocytes and may serve to limit the inflammatory response to and tissue injury resulting from bacterial infection.


Asunto(s)
Quimiocinas CXC , Proteínas del Sistema Complemento/deficiencia , Neumonía Bacteriana/inmunología , Infecciones por Pseudomonas/inmunología , Pseudomonas aeruginosa/inmunología , Animales , Quimiocina CXCL1 , Quimiocinas/inmunología , Factores Quimiotácticos/inmunología , Quimiotaxis de Leucocito/inmunología , Complemento C3/inmunología , Complemento C3/metabolismo , Convertasas de Complemento C3-C5/inmunología , Convertasas de Complemento C3-C5/metabolismo , Modelos Animales de Enfermedad , Femenino , Interacciones Huésped-Parásitos/inmunología , Péptidos y Proteínas de Señalización Intercelular/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Mortalidad , Peroxidasa/inmunología , Neumonía/inmunología , Neumonía/metabolismo , Neumonía Bacteriana/fisiopatología , Infecciones por Pseudomonas/fisiopatología , Alveolos Pulmonares/inmunología , Alveolos Pulmonares/microbiología , Fenómenos Fisiológicos Respiratorios
8.
Am J Pathol ; 161(5): 1849-59, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12414531

RESUMEN

The complement activation product, C5a, is a powerful phlogistic factor. Using antibodies to detect human or rat C5a, incubation at pH 7.4 of human blood neutrophils or rat alveolar macrophages (AMs) with C5 in the presence of phorbol 12-myristate 13-acetate (PMA) led to generation of C5a. Rat AMs activated with lipopolysaccharide also generated C5a from C5. With activated neutrophils, extensive cleavage of C5 occurred, whereas activated macrophages had much more selective proteolytic activity for C5. Peripheral blood human or rat mononuclear cells and rat alveolar epithelial cells when stimulated with phorbol ester all failed to demonstrate an ability to cleave C5, suggesting a specificity of C5 cleavage by phagocytic cells. With rat AMs, C5a generation was time-dependent and was blocked if AMs were pretreated with inhibitors of transcription or protein synthesis (actinomycin D or cycloheximide). Similar treatment of activated human polymorphonuclear leukocytes only partially reduced C5a generation after addition of C5. C5a generated by activated AMs was biologically (chemotactically) active. This generation was sensitive to serine protease inhibitors but not to other classes of inhibitors. These data indicate that phagocytic cells, especially lung macrophages, can generate C5a from C5. In the context of the lung, this may represent an important C5a-generating pathway that is independent of the plasma complement system.


Asunto(s)
Complemento C5a/biosíntesis , Fagocitos/inmunología , Animales , Células Cultivadas , Quimiotaxis/efectos de los fármacos , Complemento C5/análisis , Complemento C5/metabolismo , Ensayo de Actividad Hemolítica de Complemento , Inhibidores Enzimáticos/farmacología , Humanos , Cinética , Pulmón/citología , Pulmón/inmunología , Macrófagos Alveolares/efectos de los fármacos , Macrófagos Alveolares/inmunología , Neutrófilos/efectos de los fármacos , Neutrófilos/inmunología , Inhibidores de la Síntesis de la Proteína/farmacología , Proteínas Inhibidoras de Proteinasas Secretoras , Proteínas/farmacología , Ratas , Inhibidores de Serina Proteinasa/farmacología , Inhibidores de Tripsina/farmacología
9.
J Immunol ; 169(6): 3223-31, 2002 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-12218141

RESUMEN

This study defines the molecular basis for defects in innate immunity involving neutrophils during cecal ligation/puncture (CLP)-induced sepsis in rats. Blood neutrophils from CLP rats demonstrated defective phagocytosis and defective assembly of NADPH oxidase, the latter being due to the inability of p47(phox) to translocate from the cytosol to the cell membrane of neutrophils after cell stimulation by phorbol ester (PMA). The appearance of these defects was prevented by in vivo blockade of C5a in CLP rats. In vitro exposure of neutrophils to C5a led to reduced surface expression of C5aR and defective assembly of NADPH oxidase, as defined by failure in phosphorylation of p47(phox) and its translocation to the cell membrane, together with failure in phosphorylation of p42/p44 mitogen-activated protein kinases. These data identify a molecular basis for defective innate immunity involving neutrophils during sepsis.


Asunto(s)
Complemento C5a/farmacología , Neutrófilos/inmunología , Estallido Respiratorio/inmunología , Sepsis/inmunología , Animales , Antígenos CD/análisis , Ciego , Complemento C5a/inmunología , Complemento C5a/metabolismo , Humanos , Peróxido de Hidrógeno/metabolismo , Sueros Inmunes/administración & dosificación , Inmunidad Innata , Inmunización Pasiva , Ligadura , MAP Quinasa Quinasa 1 , Masculino , Proteína Quinasa 1 Activada por Mitógenos/antagonistas & inhibidores , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos , Quinasas de Proteína Quinasa Activadas por Mitógenos/antagonistas & inhibidores , Quinasas de Proteína Quinasa Activadas por Mitógenos/metabolismo , Proteínas Quinasas Activadas por Mitógenos/antagonistas & inhibidores , Proteínas Quinasas Activadas por Mitógenos/metabolismo , NADPH Oxidasas/antagonistas & inhibidores , NADPH Oxidasas/metabolismo , Activación Neutrófila/efectos de los fármacos , Activación Neutrófila/inmunología , Neutrófilos/efectos de los fármacos , Neutrófilos/enzimología , Neutrófilos/metabolismo , Disfunción de Fagocito Bactericida/inmunología , Fosfoproteínas/antagonistas & inhibidores , Fosfoproteínas/metabolismo , Fosforilación/efectos de los fármacos , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , Proteínas Serina-Treonina Quinasas/metabolismo , Punciones , Ratas , Ratas Long-Evans , Receptor de Anafilatoxina C5a , Receptores de Complemento/análisis , Receptores de Complemento/antagonistas & inhibidores , Sepsis/patología , Sepsis/prevención & control , Transducción de Señal/inmunología , Acetato de Tetradecanoilforbol/antagonistas & inhibidores , Acetato de Tetradecanoilforbol/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA